课题基金 / 基金详情

POTENTIATION OF ENDOTHELIUM-DEPENDENT VASODILATION IN HUMANS BY L-ARGININE

POTENTIATION OF ENDOTHELIUM-DEPENDENT VASODILATION IN HUMANS BY L-ARGININE
L-精氨酸增强人体内皮依赖性血管舒张作用
批准号:
3843417
负责人:
J A PANZA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

J A PANZA的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
L-arginine is the natural precursor of endothelium-derived nitric oxide, a mediator in the regulation of vascular tone by endothelial cells. The present investigation was undertaken to determine whether increased availability of nitric oxide precursor in the endothelial cells can potentiate the response to endothelium-dependent vasodilators. For this purpose, 12 normal subjects (age 49+7 years; 7 males and 5 females) were studied with infusion of acetylcholine, an endothelium-dependent vasodilator and sodium nitroprusside, a direct smooth muscle dilator, before and after the infusion of L-arginine. The effect of D-arginine (an isomer that is not a precursor of nitric oxide) on the response to acetylcholine was studied in 8 of these subjects. Drugs were infused into the brachial artery and the response of the forearm blood flow was measured by strain gauge plethysmography. At the doses infused (40 microm/min), L-arginine or D-arginine did not change blood flow. However, the vasodilator response to acetylcholine observed with L-arginine was significantly greater than that observed with acetylcholine alone. Conversely, L-arginine did not modify the response to sodium nitroprusside. Also, the response to acetylcholine was not modified by D- arginine. These findings indicate the availability of precursor of endothelium-derived nitric oxide is a rate-limiting step in endothelium- dependent vascular relaxation in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INCREASED ENDOTHELIN VASOCONSTRICTOR ACTIVITY IN ESSENTIAL HYPERTENSION
SILENT ISCHEMIA IN MILDLY SYMPTOMATIC CORONARY ARTERY DISEASE
ASSESSMENT OF MICROVASCULAR ENDOTHELIUM--DEPENDENT REACTIVITY
SIGNIFICANCE OF MITRAL VALVE PROLAPSE IN HYPERTROPHIC CARDIOMYOPATHY